Divi's Laboratories Ltd. (DIVI)

Currency in INR
6,599.20
-53.35(-0.80%)
Delayed Data·

DIVI Financial Summary

Key Ratios

P/E Ratio80.51
Price/Book11.94
Debt / Equity0.03%
Return on Equity15.35%
Dividend Yield0.45%
EBITDA29.68B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 82.53%
Dividend Yield
0.45%
Industry Median 0.73%
Annualised payout
30.00
Paid annually
5-Years Growth
+13.40%
Growth Streak

Earnings

Latest Release
May 17, 2025
EPS / Forecast
24.90 / 20.67
Revenue / Forecast
25.85B / 25.78B
EPS Revisions
Last 90 days

FAQ

What were Divi's Laboratories Ltd.'s earnings for the latest quarter?

The Divi's Laboratories Ltd. EPS (TTM) is 82.53. Divi's Laboratories Ltd. reported sales of 25,850.00, net income of 6,620.00, and EPS of 24.90 for the latest quarter.

What was Divi's Laboratories Ltd.'s net income for the latest quarter?

Divi's Laboratories Ltd.'s net income for the latest quarter was 6,620.00.

How did Divi's Laboratories Ltd.'s performance compare year-over-year in the latest quarter?

The company's revenue moved from 23,190.00 in the previous quarter to 25,850.00 in the latest quarter, and net income moved from 5,890.00 to 6,620.00 compared to the previous quarter.

What is Divi's Laboratories Ltd.'s net profit margin on a TTM basis?

Divi's Laboratories Ltd.'s trailing twelve months (TTM) net profit margin is 23.41%.

How does Divi's Laboratories Ltd.'s debt to equity ratio compare to industry standards?

Divi's Laboratories Ltd.'s total debt-to-equity ratio is 0.03%.

What is Divi's Laboratories Ltd.'s return on investment on a TTM basis?

Divi's Laboratories Ltd.'s trailing twelve months (TTM) return on investment (ROI) is 15.35%.

What were Divi's Laboratories Ltd.'s total assets and liabilities in the latest quarter?

As of the latest quarter, Divi's Laboratories Ltd. reported total assets of 169,320.00 million and total liabilities of 14,520.00 million.

How has Divi's Laboratories Ltd.'s total revenue grown this year?

Divi's Laboratories Ltd.'s total revenue was 23,190.00 in the previous quarter and 25,850.00 in the latest quarter.

What is Divi's Laboratories Ltd.'s gross margin on a TTM basis?

Divi's Laboratories Ltd.'s trailing twelve months (TTM) gross margin is 60.20%.

What was Divi's Laboratories Ltd.'s revenue per share for the latest quarter?

Divi's Laboratories Ltd.'s revenue per share for the latest quarter was 297.44.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.